QUARTERLY FOCUS ISSUE: PREVENTION/OUTCOMES: COST-EFFECTIVENESS
Induced Cardiovascular Procedural Costs and Resource Consumption Patterns After Coronary Artery Calcium ScreeningResults From the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) Study
Leslee J. Shaw, PhD*,
James K. Min, MD ,
Matthew Budoff, MD ,
Heidi Gransar, MS ,
Alan Rozanski, MD||,
Sean W. Hayes, MD ,
John D. Friedman, MD ,
Romalisa Miranda, MPH ,
Nathan D. Wong, PhD¶ and
Daniel S. Berman, MD ,*
* Emory University School of Medicine, Atlanta, Georgia
Weill Medical College of Cornell University, The New York Presbyterian Hospital, New York, New York
Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California
Cedars-Sinai Medical Center, Los Angeles, California
|| St. Luke's Roosevelt Hospital, New York, New York
¶ University of California at Irvine, Irvine, California
Manuscript received March 27, 2009;
revised manuscript received June 8, 2009,
accepted July 6, 2009.
* Reprint requests and correspondence: Dr. Daniel S. Berman, Department of Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Room 1258, Los Angeles, California 90048 (Email: bermand{at}cshs.org).
Objectives: We prospectively evaluated procedural costs and resource consumption patterns in the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study after coronary calcium (CAC) measurements.
Background: Controversy surrounds expansion of cardiovascular disease (CVD) screening to include atherosclerosis imaging as the result of concern whether induced costs will outweigh any benefit.
Methods: Detailed risk factor and CAC measurements with 4-year follow-up for CVD death or myocardial infarction and procedures were performed. Costs were estimated with the use of Medicare reimbursement rates (discounted and inflation corrected). Cox survival analysis was used to estimate procedures and events.
Results: CAC scores varied widely but were skewed toward low scores with 56.7% of screened subjects having CAC scores 10 and only 8.2% having CAC scores 400. Noninvasive testing was infrequent and medical costs were low among subjects with low CAC scores, both rising progressively with increasing CAC scores (p < 0.001), particularly in the 31 (2.2% of subjects) that had CAC scores 1,000. Similarly, invasive coronary angiography rose progressively with increasing scores (p < 0.001) but occurred exclusively among subjects first undergoing noninvasive testing and overall, was performed in only 19.4% of subjects with CAC scores 1,000.
Conclusions: CAC scanning is associated with a marked differential in downstream frequency of medical tests and costs, ranging from a very low frequency of testing and invasive procedures among a predominantly large percentage of subjects with low CAC scores, to selectively concentrated testing and procedures among a small number of subjects with CAC scores >400. Thus, CAC scanning appears to foster efficient selective testing patterns among asymptomatic individuals at risk for CVD.
Key Words: screening cost utilization prognosis
|
Abbreviations and Acronyms
| | CAC = coronary artery calcium/calcification | | CCTA = coronary computed tomographic angiography | | CVD = cardiovascular disease | | ECG = electrocardiographic/electrocardiogram | | FRS = Framingham Risk Score | | HU = Hounsfield units | | ICA = invasive coronary angiography | | MI = myocardial infarction |
|
Related Articles
-
Selective Use of Coronary Artery Calcium Screening: Worth the Cost?
- Roger S. Blumenthal, Chao-Wei Hwang, and Khurram Nasir
J. Am. Coll. Cardiol. 2009 54: 1268-1270.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A26.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. W. McEvoy, M. J. Blaha, K. Nasir, Y. E. Yoon, E.-K. Choi, I.-S. Cho, E.-J. Chun, S.-I. Choi, J. J. Rivera, R. S. Blumenthal, et al.
Impact of Coronary Computed Tomographic Angiography Results on Patient and Physician Behavior in a Low-Risk Population
Arch Intern Med,
July 25, 2011;
171(14):
1260 - 1268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Hlatky and P. A. Heidenreich
The Year in Epidemiology, Health Services Research, and Outcomes Research
J. Am. Coll. Cardiol.,
May 10, 2011;
57(19):
1859 - 1866.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Ferket, T. S. S. Genders, E. B. Colkesen, J. J. Visser, S. Spronk, E. W. Steyerberg, and M. G. M. Hunink
Systematic Review of Guidelines on Imaging of Asymptomatic Coronary Artery Disease
J. Am. Coll. Cardiol.,
April 12, 2011;
57(15):
1591 - 1600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rozanski, H. Gransar, L. J. Shaw, J. Kim, L. Miranda-Peats, N. D. Wong, J. S. Rana, R. Orakzai, S. W. Hayes, J. D. Friedman, et al.
Impact of Coronary Artery Calcium Scanning on Coronary Risk Factors and Downstream Testing: The EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) Prospective Randomized Trial
J. Am. Coll. Cardiol.,
April 12, 2011;
57(15):
1622 - 1632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Blaha, R. S. Blumenthal, M. J. Budoff, and K. Nasir
Understanding the Utility of Zero Coronary Calcium as a Prognostic Test: A Bayesian Approach
Circ Cardiovasc Qual Outcomes,
March 1, 2011;
4(2):
253 - 256.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Blumenthal, C.-W. Hwang, and K. Nasir
Selective Use of Coronary Artery Calcium Screening: Worth the Cost?
J. Am. Coll. Cardiol.,
September 29, 2009;
54(14):
1268 - 1270.
[Full Text]
[PDF]
|
 |
|
|